|

RP1, intra-tumoral injection, oncolytic virus Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Replimune Inc.1

Indications

  • Locally Advanced Cutaneous Squamous Cell Carcinoma1
  • Cutaneous Squamous Cell Carcinoma1
  • Basal Cell Carcinoma1
  • Merkel Cell Carcinoma1
  • Melanoma1

Phoenix, Arizona1 trial

Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin Malignancies

Medical Dermatology Specialists

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.